Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Acute myeloid leukemia 💬 18 genes, 37 drugs (DrugBank) and 71 diseases |
RARA [1] RARA 💬Acute myeloid leukemia
|
Isotretinoin Isotretinoin 💬Acute myeloid leukemia
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||||||||||||
| 2 | Autoimmune thyroid disease 💬 42 genes, 16 drugs (DrugBank) and 38 diseases |
CTLA4 [1] CTLA4 💬Autoimmune thyroid disease
|
Ipilimumab Ipilimumab 💬Autoimmune thyroid disease
| Ipilimumab | 013 [9] 13, 46, 49, 50, 51, 53, 96, 97, 159 💬2. Autoimmune thyroid disease
|
||||||||||||||||||||||||||||||||||||||||||
| 3 | Cell adhesion molecule (CAM) interaction 💬 41 genes, 32 drugs (DrugBank) and 40 diseases |
CTLA4 [1] CTLA4 💬Cell adhesion molecule (CAM) interaction
|
Ipilimumab Ipilimumab 💬Cell adhesion molecule (CAM) interaction
| Ipilimumab | 013 [9] 13, 46, 49, 50, 51, 53, 96, 97, 159 💬3. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||||||||||||||
| 4 | Cell adhesion molecule (CAM) interaction 💬 41 genes, 32 drugs (DrugBank) and 40 diseases |
PDCD1 [1] PDCD1 💬Cell adhesion molecule (CAM) interaction
|
Nivolumab Nivolumab 💬Cell adhesion molecule (CAM) interaction
| Nivolumab | 013 [12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬4. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||||||||||||||
| 5 | Circadian entrainment 💬 22 genes, 42 drugs (DrugBank) and 62 diseases |
MTNR1A [2] MTNR1A, MTNR1B 💬
|
Melatonin Melatonin 💬Circadian entrainment
| Melatonin | 002 [18] 2 , 6 , 8 , 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬5. Circadian entrainment
|
||||||||||||||||||||||||||||||||||||||||||
| 6 | Estrogen signaling pathway 💬 20 genes, 80 drugs (DrugBank) and 70 diseases |
RARA [1] RARA 💬Estrogen signaling pathway
|
Isotretinoin Isotretinoin 💬Estrogen signaling pathway
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬6. Estrogen signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||
| 7 | Gastric cancer 💬 23 genes, 41 drugs (DrugBank) and 69 diseases |
RARB [1] RARB 💬Gastric cancer
|
Isotretinoin Isotretinoin 💬Gastric cancer
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬7. Gastric cancer
|
||||||||||||||||||||||||||||||||||||||||||
| 8 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
MC1R [1] MC1R 💬Hormone signaling
|
Afamelanotide Afamelanotide 💬Hormone signaling
| Afamelanotide | 159 [2] 159, 254 💬8. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||
| 9 | Hormone signaling 💬 64 genes, 217 drugs (DrugBank) and 150 diseases |
MC1R [1] MC1R 💬Hormone signaling
|
Afamelanotide acetate Afamelanotide acetate 💬Hormone signaling
| Afamelanotide | 159 [2] 159, 254 💬8. Hormone signaling
|
||||||||||||||||||||||||||||||||||||||||||
| 10 | Melanogenesis 💬 7 genes, 18 drugs (DrugBank) and 34 diseases |
MC1R [1] MC1R 💬Melanogenesis
|
Afamelanotide Afamelanotide 💬Melanogenesis
| Afamelanotide | 159 [2] 159, 254 💬10. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||||
| 11 | Melanogenesis 💬 7 genes, 18 drugs (DrugBank) and 34 diseases |
MC1R [1] MC1R 💬Melanogenesis
|
Afamelanotide acetate Afamelanotide acetate 💬Melanogenesis
| Afamelanotide | 159 [2] 159, 254 💬10. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||||
| 12 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
MC1R [1] MC1R 💬Neuroactive ligand-receptor interaction
|
Afamelanotide Afamelanotide 💬Neuroactive ligand-receptor interaction
| Afamelanotide | 159 [2] 159, 254 💬12. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||
| 13 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
MC1R [1] MC1R 💬Neuroactive ligand-receptor interaction
|
Afamelanotide acetate Afamelanotide acetate 💬Neuroactive ligand-receptor interaction
| Afamelanotide | 159 [2] 159, 254 💬12. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||
| 14 | Neuroactive ligand-receptor interaction 💬 156 genes, 371 drugs (DrugBank) and 171 diseases |
MTNR1A [2] MTNR1A, MTNR1B 💬
|
Melatonin Melatonin 💬Neuroactive ligand-receptor interaction
| Melatonin | 002 [18] 2 , 6 , 8 , 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬14. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||
| 15 | Non-small cell lung cancer 💬 21 genes, 39 drugs (DrugBank) and 57 diseases |
RARB [1] RARB 💬Non-small cell lung cancer
|
Isotretinoin Isotretinoin 💬Non-small cell lung cancer
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬15. Non-small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||||||
| 16 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
RARA [2] RARA, RARB 💬
|
Isotretinoin Isotretinoin 💬Pathways in cancer
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬16. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||
| 17 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 70 drugs (DrugBank) and 104 diseases |
PDCD1 [1] PDCD1 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
|
Nivolumab Nivolumab 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Nivolumab | 013 [12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬17. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||||||||
| 18 | Rheumatoid arthritis 💬 39 genes, 59 drugs (DrugBank) and 85 diseases |
CTLA4 [1] CTLA4 💬Rheumatoid arthritis
|
Ipilimumab Ipilimumab 💬Rheumatoid arthritis
| Ipilimumab | 013 [9] 13, 46, 49, 50, 51, 53, 96, 97, 159 💬18. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||
| 19 | Small cell lung cancer 💬 15 genes, 47 drugs (DrugBank) and 63 diseases |
RARB [1] RARB 💬Small cell lung cancer
|
Isotretinoin Isotretinoin 💬Small cell lung cancer
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬19. Small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||||||
| 20 | T cell receptor signaling pathway 💬 35 genes, 58 drugs (DrugBank) and 88 diseases |
CTLA4 [1] CTLA4 💬T cell receptor signaling pathway
|
Ipilimumab Ipilimumab 💬T cell receptor signaling pathway
| Ipilimumab | 013 [9] 13, 46, 49, 50, 51, 53, 96, 97, 159 💬20. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||
| 21 | T cell receptor signaling pathway 💬 35 genes, 58 drugs (DrugBank) and 88 diseases |
PDCD1 [1] PDCD1 💬T cell receptor signaling pathway
|
Nivolumab Nivolumab 💬T cell receptor signaling pathway
| Nivolumab | 013 [12] 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬21. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||
| 22 | Th17 cell differentiation 💬 57 genes, 88 drugs (DrugBank) and 111 diseases |
RARA [1] RARA 💬Th17 cell differentiation
|
Isotretinoin Isotretinoin 💬Th17 cell differentiation
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬22. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||
| 23 | Transcriptional misregulation in cancer 💬 28 genes, 64 drugs (DrugBank) and 83 diseases |
RARA [1] RARA 💬Transcriptional misregulation in cancer
|
Isotretinoin Isotretinoin 💬Transcriptional misregulation in cancer
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬23. Transcriptional misregulation in cancer
|
Acute myeloid leukemia
18 genes, 37 drugs (DrugBank) and 71 diseases
Autoimmune thyroid disease
42 genes, 16 drugs (DrugBank) and 38 diseases
Cell adhesion molecule (CAM) interaction
41 genes, 32 drugs (DrugBank) and 40 diseases
Circadian entrainment
22 genes, 42 drugs (DrugBank) and 62 diseases
Estrogen signaling pathway
20 genes, 80 drugs (DrugBank) and 70 diseases
Gastric cancer
23 genes, 41 drugs (DrugBank) and 69 diseases
Hormone signaling
64 genes, 217 drugs (DrugBank) and 150 diseases
Melanogenesis
7 genes, 18 drugs (DrugBank) and 34 diseases
Neuroactive ligand-receptor interaction
156 genes, 371 drugs (DrugBank) and 171 diseases
Non-small cell lung cancer
21 genes, 39 drugs (DrugBank) and 57 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
34 genes, 70 drugs (DrugBank) and 104 diseases
Rheumatoid arthritis
39 genes, 59 drugs (DrugBank) and 85 diseases
Small cell lung cancer
15 genes, 47 drugs (DrugBank) and 63 diseases
T cell receptor signaling pathway
35 genes, 58 drugs (DrugBank) and 88 diseases
Th17 cell differentiation
57 genes, 88 drugs (DrugBank) and 111 diseases
Transcriptional misregulation in cancer
28 genes, 64 drugs (DrugBank) and 83 diseases
